NO850217L - Fremgangsmaate for fremstilling av et farmatologisk aktivert sulfonylurinstoff-derivat - Google Patents
Fremgangsmaate for fremstilling av et farmatologisk aktivert sulfonylurinstoff-derivatInfo
- Publication number
- NO850217L NO850217L NO850217A NO850217A NO850217L NO 850217 L NO850217 L NO 850217L NO 850217 A NO850217 A NO 850217A NO 850217 A NO850217 A NO 850217A NO 850217 L NO850217 L NO 850217L
- Authority
- NO
- Norway
- Prior art keywords
- reaction
- methylpyrazinyl
- carboxamido
- ethyl
- product
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 13
- 239000004615 ingredient Substances 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 claims description 28
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- IMEZLHZLIANIAS-UHFFFAOYSA-N 5-methyl-n-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(N)(=O)=O)C=C1 IMEZLHZLIANIAS-UHFFFAOYSA-N 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- JFRFGCASIOOBDA-UHFFFAOYSA-N 2,2,2-trichloro-n-cyclohexylacetamide Chemical compound ClC(Cl)(Cl)C(=O)NC1CCCCC1 JFRFGCASIOOBDA-UHFFFAOYSA-N 0.000 claims description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 2
- 239000000010 aprotic solvent Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- WUESWDIHTKHGQA-UHFFFAOYSA-N cyclohexylurea Chemical compound NC(=O)NC1CCCCC1 WUESWDIHTKHGQA-UHFFFAOYSA-N 0.000 claims description 2
- 150000004678 hydrides Chemical class 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims 1
- 239000000047 product Substances 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 12
- 229960001381 glipizide Drugs 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 9
- KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- -1 2-methylpyrazinyl group Chemical group 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D521/00—Heterocyclic compounds containing unspecified hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI840209A FI69303C (fi) | 1984-01-19 | 1984-01-19 | Foerfarande foer framstaellning av ett farmakologiskt verksamtsulfonylureaderivat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO850217L true NO850217L (no) | 1985-07-22 |
Family
ID=8518397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO850217A NO850217L (no) | 1984-01-19 | 1985-01-18 | Fremgangsmaate for fremstilling av et farmatologisk aktivert sulfonylurinstoff-derivat |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0149592A3 (xx) |
| CS (1) | CS249534B2 (xx) |
| DD (1) | DD228251A5 (xx) |
| DK (1) | DK18985A (xx) |
| FI (1) | FI69303C (xx) |
| NO (1) | NO850217L (xx) |
| PL (1) | PL251605A1 (xx) |
| SU (1) | SU1340584A3 (xx) |
| ZA (1) | ZA8410079B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107434788B (zh) * | 2017-09-11 | 2018-06-15 | 威海迪素制药有限公司 | 一种格列吡嗪的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU162761B (xx) * | 1971-04-06 | 1973-04-28 |
-
1984
- 1984-01-19 FI FI840209A patent/FI69303C/sv not_active IP Right Cessation
- 1984-12-27 ZA ZA8410079A patent/ZA8410079B/xx unknown
-
1985
- 1985-01-15 DK DK18985A patent/DK18985A/da not_active Application Discontinuation
- 1985-01-16 SU SU853837681A patent/SU1340584A3/ru active
- 1985-01-16 CS CS30785A patent/CS249534B2/cs unknown
- 1985-01-17 EP EP85850019A patent/EP0149592A3/en not_active Withdrawn
- 1985-01-17 DD DD27262785A patent/DD228251A5/de unknown
- 1985-01-18 NO NO850217A patent/NO850217L/no unknown
- 1985-01-18 PL PL25160585A patent/PL251605A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS249534B2 (en) | 1987-03-12 |
| ZA8410079B (en) | 1985-08-28 |
| FI840209A0 (fi) | 1984-01-19 |
| EP0149592A2 (en) | 1985-07-24 |
| EP0149592A3 (en) | 1986-06-04 |
| PL251605A1 (en) | 1985-10-22 |
| FI840209A (fi) | 1985-07-20 |
| DD228251A5 (de) | 1985-10-09 |
| FI69303B (fi) | 1985-09-30 |
| DK18985D0 (da) | 1985-01-15 |
| SU1340584A3 (ru) | 1987-09-23 |
| FI69303C (fi) | 1986-01-10 |
| DK18985A (da) | 1985-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4875278B2 (ja) | 置換スルホニルアミノメチル安息香酸（誘導体）およびその製造法 | |
| JPS6327471A (ja) | 光学活性なベンゼンスルホンアミド誘導体の製造法 | |
| US2407309A (en) | Chemotherapeutic agents of the sulphonamide type | |
| NO850217L (no) | Fremgangsmaate for fremstilling av et farmatologisk aktivert sulfonylurinstoff-derivat | |
| NO171182B (no) | Vandig geldannende blanding egnet for selektiv permeabilitetsmodifikasjon av underjordiske lag ved hydrokarbonutvinning | |
| US2953578A (en) | Sulfonyl urea compounds and a process of making same | |
| NO166636B (no) | Sprengstoff omfattende en blanding av et nitrat-olje sprengstoff og et vann-i-olje emulsjonssprengstoff og fremgangsmaate til dets fremstilling. | |
| JPH07242604A (ja) | ４，６−ジアミノレゾルシノールおよびその前駆体の製造方法 | |
| US3097240A (en) | Novel sulfonyl-ureas | |
| DE1568626C3 (de) | Benzolsulfonyl-harnstoffe, ihre Salze, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| HU188805B (en) | Process for producing sulfonylurea derivatives and pharmaceutical compositions containing them as active agents | |
| KR100712234B1 (ko) | 글리메피라이드의 제조방법 | |
| DE2256979A1 (de) | Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung | |
| JP3468543B2 (ja) | ２−ブチル−４−クロロ−５−メチルイミダゾール及びその合成方法 | |
| JP2006512305A (ja) | ２−アミノ−４−クロロ−６−アルコキシピリミジンの製造方法 | |
| MXPA99006794A (en) | An enhanced procedure for the preparation of oral hypoglycaemias benzensulfonylureas of second generation | |
| JP3721540B2 (ja) | ピロリジン誘導体 | |
| NO128892B (xx) | ||
| JPH051024A (ja) | スルホンアミド誘導体 | |
| JP4114911B2 (ja) | ４−ヒドロキシベンゼンスルホンアニリドの製造方法 | |
| JPH0867677A (ja) | アミン系化合物の製造方法 | |
| DE2157607B2 (de) | Sulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| JPS6248667A (ja) | チオカルバメ−ト誘導体の製造法 | |
| JPS6038385B2 (ja) | ２−ベンゾチアゾロン類の製造方法 | |
| DE1443878B2 (de) | Verfahren zur herstellung von benzol- sulfonylharnstoffen |